CORE--PEPTIDE SYNTHESIS AND ANALYSIS

核心--肽合成与分析

基本信息

  • 批准号:
    6605454
  • 负责人:
  • 金额:
    $ 19.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-02 至 2003-02-28
  • 项目状态:
    已结题

项目摘要

Description: (Applicant's Description) The broad objective of this Shared Facility is to make peptide sequencing using Edman chemistry and peptide synthesis services, as well as amino acid composition analysis, readily available to Cancer Center researchers. Identification of an isolated protein, whether a previously described or previously unreported protein, is an essential part of many research projects and commonly is best achieved by N-terminal sequencing. The design of oligonucleotide probes for molecular biological studies is most often based upon limited peptide sequence obtained from N-terminal sequence analysis. There are many needs for synthesis of peptides: frequently to be conjugated to protein and used as specific immunogens. The Cancer Center?s Shared Facility for Peptide Analysis & Synthesis sequences 150-250 peptides and synthesizes 90-120 peptides annually. More than 70 percent of these services are for Cancer Center faculty. The present extent of usage of the Facility is indicative of the need for and value of these services. Their importance in helping to achieve the goals of many Cancer Center research projects is outlined elsewhere in this renewal proposal. Recently, methodologies for obtaining internal N-terminal sequence of peptides derived from proteins electroblotted to PVDF have been established and made available in this Facility. Also, the Facility's web page has been enhanced and now includes full descriptions of services offered and methodologies to be employed. The methodologies used by the Facility have matured and are no longer subject to rapid change. There is constant interaction with the Mass Spectrometry Shared Facility to ensure that the most appropriate and efficient techniques are recommended in each experimental situation. In addition, it is usual practice to utilize MALDI TOF MS analysis to verify the composition of peptides synthesized and to select the most desirable peptides for sequence analysis. It is predictable that MS will be used increasingly for many sequencing tasks.
描述:(申请人描述)本次共享的总体目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN R BAKER其他文献

JOHN R BAKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN R BAKER', 18)}}的其他基金

CORE--PEPTIDE SYNTHESIS AND ANALYSIS
核心--肽合成与分析
  • 批准号:
    6434908
  • 财政年份:
    2001
  • 资助金额:
    $ 19.59万
  • 项目类别:
CORE--PEPTIDE SYNTHESIS AND ANALYSIS
核心--肽合成与分析
  • 批准号:
    6353480
  • 财政年份:
    2000
  • 资助金额:
    $ 19.59万
  • 项目类别:
CORE--PEPTIDE SYNTHESIS AND ANALYSIS
核心--肽合成与分析
  • 批准号:
    6299979
  • 财政年份:
    2000
  • 资助金额:
    $ 19.59万
  • 项目类别:
BASIC AND CLINICAL STUDIES IN ATHEROSCLEROSIS
动脉粥样硬化的基础和临床研究
  • 批准号:
    2637593
  • 财政年份:
    1994
  • 资助金额:
    $ 19.59万
  • 项目类别:
BASIC AND CLINICAL STUDIES IN ATHEROSCLEROSIS
动脉粥样硬化的基础和临床研究
  • 批准号:
    2027366
  • 财政年份:
    1994
  • 资助金额:
    $ 19.59万
  • 项目类别:
BASIC AND CLINICAL STUDIES IN ATHEROSCLEROSIS
动脉粥样硬化的基础和临床研究
  • 批准号:
    2212633
  • 财政年份:
    1994
  • 资助金额:
    $ 19.59万
  • 项目类别:
BASIC AND CLINICAL STUDIES IN ATHEROSCLEROSIS
动脉粥样硬化的基础和临床研究
  • 批准号:
    2212632
  • 财政年份:
    1994
  • 资助金额:
    $ 19.59万
  • 项目类别:
BASIC AND CLINICAL STUDIES IN ATHEROSCLEROSIS
动脉粥样硬化的基础和临床研究
  • 批准号:
    2212631
  • 财政年份:
    1994
  • 资助金额:
    $ 19.59万
  • 项目类别:
CARILAGE MATRIX PROTEIN INTERACTIONS--CHANGES WITH AGE
软骨基质蛋白相互作用——随年龄的变化
  • 批准号:
    3122044
  • 财政年份:
    1992
  • 资助金额:
    $ 19.59万
  • 项目类别:
CARTILAGE MATRIX PROTEIN INTERACTIONS--CHANGES WITH AGE
软骨基质蛋白相互作用——随年龄变化
  • 批准号:
    2051305
  • 财政年份:
    1992
  • 资助金额:
    $ 19.59万
  • 项目类别:

相似海外基金

Molecular Imaging Biomedical Resource Core
分子成像生物医学资源核心
  • 批准号:
    10747619
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Biomedical Resource Core
生物医学资源核心
  • 批准号:
    10747705
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Intravital Microscopy Biomedical Resource Core
活体显微镜生物医学资源核心
  • 批准号:
    10747618
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Biomedical Resource Core
生物医学资源核心
  • 批准号:
    10754083
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
  • 批准号:
    10797623
  • 财政年份:
    2022
  • 资助金额:
    $ 19.59万
  • 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
  • 批准号:
    10653773
  • 财政年份:
    2022
  • 资助金额:
    $ 19.59万
  • 项目类别:
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
国家电子自旋共振光谱生物医学资源 (ACERT)
  • 批准号:
    10430665
  • 财政年份:
    2022
  • 资助金额:
    $ 19.59万
  • 项目类别:
The 1958 Birth Cohort Biomedical Resource - facilitating access to data and samples and enhancing future utility
1958 年出生队列生物医学资源 - 促进数据和样本的获取并增强未来的效用
  • 批准号:
    G1001799/2
  • 财政年份:
    2013
  • 资助金额:
    $ 19.59万
  • 项目类别:
    Research Grant
The 1958 Birth Cohort Biomedical Resource - facilitating access to data and samples and enhancing future utility
1958 年出生队列生物医学资源 - 促进数据和样本的获取并增强未来的效用
  • 批准号:
    G1001799/1
  • 财政年份:
    2011
  • 资助金额:
    $ 19.59万
  • 项目类别:
    Research Grant
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群
  • 批准号:
    7894014
  • 财政年份:
    2009
  • 资助金额:
    $ 19.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了